Detrimental arterial inflammatory effect of microparticles circulating in preeclamptic women: Ex vivo evaluation in human arteries

Fundamental and Clinical Pharmacology

Volumn 29, Issue 5, 2015, Pages 450-461

  Boisramé Helms, Julie ^a,b   Meziani, Ferhat ^a,b   Sananès, Nicolas ^c   Boisramé, Thomas ^c   Langer, Bruno ^c   Schneider, Francis ^c   Ragot, Thierry ^d   Andriantsitohaina, Ramaroson ^e   Tesse, Angela ^f  

^a HÔPITAL CIVIL   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c HÔPITAL DE HAUTEPIERRE   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e INSERM   (France)

^f L INSTITUT DU THORAX   (France)

Author keywords

Hypertension; Nitric oxide; Preeclampsia; Pregnancy; Vascular inflammation

Indexed keywords

8 ISOPROSTANE; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; NITRIC OXIDE; PHENYLEPHRINE; SEROTONIN; SUPEROXIDE; AUTACOID; CYCLOOXYGENASE 2 INHIBITOR; NOS2 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN; VASOCONSTRICTOR AGENT;

ADULT; ARTERY; ARTERY CONSTRICTION; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; CESAREAN SECTION; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FEMALE; HUMAN; IMMUNOHISTOLOGY; MYOGRAPHY; OXIDATIVE STRESS; PLATELET MICROPARTICLE; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; BLOOD; DOSE RESPONSE; DRUG EFFECTS; MEMBRANE MICROPARTICLE; METABOLISM; OMENTUM; PATHOPHYSIOLOGY; PREGNANCY; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUE; VASCULARIZATION; VASOCONSTRICTION; YOUNG ADULT;

ADULT; ARTERIES; CELL-DERIVED MICROPARTICLES; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INFLAMMATION MEDIATORS; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; OMENTUM; OXIDATIVE STRESS; PRE-ECLAMPSIA; PREGNANCY; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUES; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; YOUNG ADULT;

EID: 84941741638     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/fcp.12136     Document Type: Article

References (41)

1. Practice ACoO. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int. J. Gynaecol. Obstet. (2002) 77 67-75.
2. Duley L. The global impact of pre-eclampsia and eclampsia. Semin. Perinatol. (2009) 33 130-137.
3. Saucedo M., Deneux-Tharaux C., Bouvier-Colle M.H. and French National Experts Committee on Maternal M. Ten years of confidential inquiries into maternal deaths in France, 1998-2007. Obstet. Gynecol. (2013) 122 752-760.
4. Khan K.S., Wojdyla D., Say L., Gulmezoglu A.M., Van Look P.F. WHO analysis of causes of maternal death: a systematic review. Lancet (2006) 367 1066-1074.
5. Gilbert J.S., Ryan M.J., LaMarca B.B., Sedeek M., Murphy S.R., Granger J.P. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am. J. Physiol. Heart Circ. Physiol. (2008) 294 H541-H550.
6. Bilodeau J.F. Review: maternal and placental antioxidant response to preeclampsia - impact on vasoactive eicosanoids. Placenta (2014) 35(Suppl) S32-S38.
7. Tomiba T., Numaguchi Y., Nishimoto Y. et al. Inhibition of COX-2 prevents hypertension and proteinuria associated with a decrease of 8-iso-PGF2alpha formation in L-NAME-treated rats. J. Hypertens. (2003) 21 601-609.
8. VanWijk M.J., Nieuwland R., Boer K., van der Post J.A., VanBavel E., Sturk A. Microparticle subpopulations are increased in preeclampsia: possible involvement in vascular dysfunction? Am. J. Obstet. Gynecol. (2002) 187 450-456.
9. Freyssinet J.M. Cellular microparticles: what are they bad or good for? J. Thromb. Haemost. (2003) 1 1655-1662.
10. Densmore J.C., Signorino P.R., Ou J. et al. Endothelium-derived microparticles induce endothelial dysfunction and acute lung injury. Shock (2006) 26 464-467.
11. Martin S., Tesse A., Hugel B. et al. Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression. Circulation (2004) 109 1653-1659.
12. Guller S., Tang Z., Ma Y.Y., Di Santo S., Sager R., Schneider H. Protein composition of microparticles shed from human placenta during placental perfusion: potential role in angiogenesis and fibrinolysis in preeclampsia. Placenta (2011) 32 63-69.
13. Marques F.K., Campos F.M., Sousa L.P., Teixeira-Carvalho A., Dusse L.M., Gomes K.B. Association of microparticles and preeclampsia. Mol. Biol. Rep. (2013) 40 4553-4559.
14. Meziani F., Tesse A., David E. et al. Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractility. Am. J. Pathol. (2006) 169 1473-1483.
15. Tesse A., Meziani F., David E. et al. Microparticles from preeclamptic women induce vascular hyporeactivity in vessels from pregnant mice through an overproduction of NO. Am. J. Physiol. Heart Circ. Physiol. (2007) 293 H520-H525.
16. Tranquilli A.L., Dekker G., Magee L. et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. (2014) 4 97-104.
17. Hugel B., Zobairi F., Freyssinet J.M. Measuring circulating cell-derived microparticles. J. Thromb. Haemost. (2004) 2 1846-1847.
18. Sincar M., Thadhani R., Karumanchi S.A. Pathogenesis of preeclampsia. Curr. Opin. Nephrol. Hypertens. (2015) 24 131-138.
19. Oliveira-Paula G.H., Lacchini R., Tanus-Santos J.E. Inducible nitric oxide synthase as a possible target in hypertension. Curr. Drug Targets (2014) 15 164-174.
20. Amoureux S., Lorgis L., Sicard P., Girard C., Rochette L., Vergely C. Vascular BDNF expression and oxidative stress during aging and the development of chronic hypertension. Fundam. Clin. Pharmacol. (2012) 26 227-234.
21. Ramond A., Godin-Ribuot D., Ribuot C. et al. Oxidative stress mediates cardiac infarction aggravation induced by intermittent hypoxia. Fundam. Clin. Pharmacol. (2013) 27 252-261.
22. De Faria A.P., Fontana V., Modolo R. et al. Plasma 8-isoprostane levels are associated with endothelial dysfunction in resistant hypertension. Clin. Chim. Acta (2014) 433 179-183.
23. Rodrigo R., Guichard C., Charles R. Clinical pharmacology and therapeutic use of antioxidant vitamins. Fundam. Clin. Pharmacol. (2007) 21 111-127.
24. Walsh S.W., Vaughan J.E., Wang Y., Roberts L.J. II. Placental isoprostane is significantly increased in preeclampsia. FASEB J. (2000) 14 1289-1296.
25. Tesse A., Martinez M.C., Hugel B. et al. Upregulation of proinflammatory proteins through NF-kappaB pathway by shed membrane microparticles results in vascular hyporeactivity. Arterioscler. Thromb. Vasc. Biol. (2005) 25 2522-2527.
26. Mastronardi M.L., Mostefai H.A., Soleti R., Agouni A., Martínez M.C., Andriantsitohaina R. Microparticles from apoptotic monocytes enhance nitrosative stress in human endothelial cells. Fundam. Clin. Pharmacol. (2011) 25 653-660.
27. Boulanger C.M. Microparticles, vascular function and hypertension. Curr. Opin. Nephrol. Hypertens. (2010) 19 177-180.
28. Tual-Chalot S., Guilbert C., Muller B., Savineau J.P., Andriantsitoaina R., Martinez M.C. Circulating microparticles from pulmonary hypertensive rats induce endothelial dysfunction. Am. J. Respir. Care Med. (2010) 182 261-268.
29. Pfister S.L. Role of platelet microparticles in the production of thromboxane by rabbit pulmonary artery. Hypertension (2004) 43 428-433.
30. Boisrame-Helms J., Delabranche X., Degirmenci S.E. et al. Pharmacological modulation of procoagulant microparticles improves haemodynamic dysfunction during septic shock in rats. Thromb. Haemost. (2014) 111 154-164.
31. Delabranche X., Boisrame-Helms J., Asfar P. et al. Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy. Intensive Care Med. (2013) 39 1695-1703.
32. Gonzalez-Quintero V.H., Jimenez J.J., Jy W. et al. Elevated plasma endothelial microparticles in preeclampsia. Am. J. Obstet. Gynecol. (2003) 189 589-593.
33. Lok C.A., Boing A.N., Reitsma P.H. et al. Expression of inflammation-related genes in endothelial cells is not directly affected by microparticles from preeclamptic patients. J. Lab. Clin. Med. (2006) 147 310-320.
34. Lok C.A., Nieuwland R., Sturk A. et al. Microparticle-associated P-selectin reflects platelet activation in preeclampsia. Platelets (2007) 18 68-72.
35. Biro E., Lok C.A., Hack C.E. et al. Cell-derived microparticles and complement activation in preeclampsia versus normal pregnancy. Placenta (2007) 28 928-935.
36. Leik C.E., Walsh S.W. Neutrophils infiltrate resistance-sized vessels of subcutaneous fat in women with preeclampsia. Hypertension (2004) 44 72-77.
37. Cadden K.A., Walsh S.W. Neutrophils, but not lymphocytes or monocytes, infiltrate maternal systemic vasculature in women with preeclampsia. Hypertens Pregnancy (2008) 27 396-405.
38. Shah T.J., Walsh S.W. Activation of NF-kappaB and expression of COX-2 in association with neutrophil infiltration in systemic vascular tissue of women with preeclampsia. Am. J. Obstet. Gynecol. (2007) 196 48 e1-48 e8.
39. Viera A.J., Mooberry M., Key N.S. Microparticles in cardiovascular disease pathophysiology and outcomes. J. Am. Soc. Hypertens. (2012) 6 243-252.
40. Boisrame-Helms J., Kremer H., Schini-Kerth V., Meziani F. Endothelial dysfunction in sepsis. Curr. Vasc. Pharmacol. (2013) 11 150-160.
41. Mortaza S., Martinez M.C., Baron-Menguy C. et al. Detrimental hemodynamic and inflammatory effects of microparticles originating from septic rats. Crit. Care Med. (2009) 37 2045-2050.